US2021345916A1PendingUtilityA1

Silicone based membranes for use in implantable glucose sensors

Assignee: DEXCOM INCPriority: May 22, 2002Filed: May 25, 2021Published: Nov 11, 2021
Est. expiryMay 22, 2022(expired)· nominal 20-yr term from priority
C08G 77/12C08G 77/20A61B 5/6848A61B 5/14865C08G 77/46A61B 5/14532C08L 83/04B33Y 70/00
81
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.

Claims

exact text as granted — not AI-modified
1 - 17 . (canceled) 
     
     
         18 . A system for measuring an analyte concentration in a host, the system comprising:
 a transcutaneous analyte sensor; and   sensor electronics configured to operatively connect to the transcutaneous analyte sensor.   
     
     
         19 . A method for processing data from a transcutaneous analyte sensor, the method comprising:
 receiving sensor data indicative of an analyte concentration in the host; and   processing, using a processor, the sensor data.

Join the waitlist — get patent alerts

Track US2021345916A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.